1 / 26

Slide 1

Slide 1. Presented By Maurice Perol at 2014 ASCO Annual Meeting. Conflict of Interest Disclosure. Presented By Maurice Perol at 2014 ASCO Annual Meeting. Limited Advancement in 2nd-Line Therapy. Presented By Maurice Perol at 2014 ASCO Annual Meeting. Ramucirumab and Angiogenesis.

cyndi
Download Presentation

Slide 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Slide 1 Presented By Maurice Perol at 2014 ASCO Annual Meeting

  2. Conflict of Interest Disclosure Presented By Maurice Perol at 2014 ASCO Annual Meeting

  3. Limited Advancement in 2nd-Line Therapy Presented By Maurice Perol at 2014 ASCO Annual Meeting

  4. Ramucirumab and Angiogenesis Presented By Maurice Perol at 2014 ASCO Annual Meeting

  5. REVEL: Study Design Presented By Maurice Perol at 2014 ASCO Annual Meeting

  6. Patient Eligibility Presented By Maurice Perol at 2014 ASCO Annual Meeting

  7. Statistical Considerations for OS Presented By Maurice Perol at 2014 ASCO Annual Meeting

  8. Patient Disposition Presented By Maurice Perol at 2014 ASCO Annual Meeting

  9. Baseline Demographics<br />and Patient Characteristics Presented By Maurice Perol at 2014 ASCO Annual Meeting

  10. Tumor Response by RECIST v1.1<br />ITT Population, Investigator Assessment Presented By Maurice Perol at 2014 ASCO Annual Meeting

  11. Progression-Free Survival<br />ITT Population, Investigator Assessment Presented By Maurice Perol at 2014 ASCO Annual Meeting

  12. Forest Plot of PFS by Subgroups<br />Unstratified Analysis Presented By Maurice Perol at 2014 ASCO Annual Meeting

  13. Post-discontinuation Therapy Presented By Maurice Perol at 2014 ASCO Annual Meeting

  14. Overall Survival<br />ITT Population Presented By Maurice Perol at 2014 ASCO Annual Meeting

  15. Forest Plot of OS by Subgroups <br />Unstratified Analysis Presented By Maurice Perol at 2014 ASCO Annual Meeting

  16. Safety Overview Presented By Maurice Perol at 2014 ASCO Annual Meeting

  17. Selected Treatment-Emergent Adverse Events Occurring in ≥20% of Patients or ≥5% Higher in the RAM+DOC Arm Presented By Maurice Perol at 2014 ASCO Annual Meeting

  18. Select AEs of Special Interest Presented By Maurice Perol at 2014 ASCO Annual Meeting

  19. REVEL: Conclusions Presented By Maurice Perol at 2014 ASCO Annual Meeting

  20. Acknowledgements Presented By Maurice Perol at 2014 ASCO Annual Meeting

  21. REVEL Investigators Presented By Maurice Perol at 2014 ASCO Annual Meeting

  22. Slide 22 Presented By Maurice Perol at 2014 ASCO Annual Meeting

  23. OS by Histology Presented By Maurice Perol at 2014 ASCO Annual Meeting

  24. PFS by Histology Presented By Maurice Perol at 2014 ASCO Annual Meeting

  25. Slide 25 Presented By Maurice Perol at 2014 ASCO Annual Meeting

  26. Slide 26 Presented By Maurice Perol at 2014 ASCO Annual Meeting

More Related